NOVIAN Health Presents at William Blair Private Equity Conference
CHICAGO – October 17, 2007 – Henry R. Appelbaum “Chip”, President and Chief Executive
Officer and Director of NOVIAN Health, Inc., presented at the William Blair & Company’s 10th Annual
Private Equity Conference held in Chicago. Mr. Appelbaum highlighted the company’s
accomplishments and the anticipated commercialization of NOVIAN Health’s Breast ILT System.
The conference provides an opportunity for private companies to present their near-term capital needs to an
audience of the leading private equity and venture investors in the U.S. The conference also highlights
the perspective and insights of William Blair & Company’s Equity Research teams, as they lead
discussions, moderate panels, and present their industry outlook to the conference participants.
NOVIAN Health Inc., located in Chicago, is a small, privately held company with proprietary
technology for the treatment of tumors using Interstitial Laser Therapy (ILT). The company has
developed, tested, and patented a minimally-invasive procedure that uses ILT (controlled heating) for
the ablation of breast tumors as an alternative to the surgically invasive, traditional “lumpectomy.” ILT
offers significant advantages over surgical removal including minimal scarring, quicker recovery times,
and only requiring local anesthesia. NOVIAN Health recently received its first FDA 510k clearance for
Fibroadenomas (benign tumors) of the breast and expects to offer its technology at centers around the
country. Their plan is to launch several centers nationwide that will be associated with existing surgical
practices. Approval for malignant tumors will also be sought.
